Literature DB >> 3882231

Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma.

I F Tannock, W K Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882231

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  Metastatic renal cell cancer--is the outlook really improving?

Authors:  J Waxman; H Thomas
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

2.  Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.

Authors:  P J Elson; L K Kvols; S E Vogl; D J Glover; R G Hahn; D L Trump; P P Carbone; J D Earle; T E Davis
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.